Is Clindamycin Palmitate Hydrochloride Injection in shortage?
Clindamycin Palmitate Hydrochloride Injection is listed by FDA as being discontinued by at least one maker (updated Mar 26, 2026).
Every listed package
FDA tracks shortages per package. What each maker reports, most recently updated first:
- Clindamycin Palmitate Hydrochloride, Injection, 75 mg/5 mL (NDC 53746-468-19)
Discontinuation of the manufacture of the drug
Maker contact: 866-525-7270
Clindamycin Palmitate Hydrochloride Injection shortage questions
Is Clindamycin Palmitate Hydrochloride Injection in shortage?
Clindamycin Palmitate Hydrochloride Injection is listed by FDA as being discontinued by at least one maker (updated Mar 26, 2026).
What should I do if I can’t get Clindamycin Palmitate Hydrochloride Injection?
Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.
Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.
